February 14, 2017
Vinergy Resources/MJ BioPharma Announces Breakthrough in Oral Cannabinoid Strip and Time Release Capsule Technologies
VANCOUVER, BRITISH COLUMBIA—(Marketwired - Feb. 14, 2017) - Vinergy Resources Ltd. (“Vinergy” or the “Company”)(CSE:VIN)(CSE:VIN.CN)(OTCQB:VNNYF)
in conjunction with its proposed acquisition of MJ Biopharma (announced
December 14, 2016) is pleased to announce a major breakthrough while
conducting research and development on oral cannabinoid complex
(Tetrahydrocannabinol (THC), Cannabidiol (CBD), Cannabinol (CBN) and
Terpenes) delivery strips and controlled time release capsule
technology. This novel approach will be the basis for several products
where water or saliva is the catalyst used to activate the carrier for
delivery and absorption of the cannabinoid complex into the body.
This unique approach forms the basis for a fundamentally new
technology and product category. The technology is called “BURST” due to
its incredibly fast action and ability to enhance the body’s absorption
of various medicinal ingredients contained in the Company’s products.
The BURST system is built on natural botanical polymers delivering
specially processed high purity cannabinoid complexes. The unique system
for cannabinoid activation maintains the natural balance of THC, CBD,
CBN and terpenes while preserving the maximum therapeutic effect and
potentially delivering it to the body faster than any currently
available delivery method. The patent pending technology allows for a
more complete palatable drug delivery system that is effective and
enhances the patient or user experience while intensifying flavour.
“This is a great breakthrough for us and the product line we
have planned. The technology can also be utilized in our time release
capsules which of course will have a slower absorption rate. We think
time release capsules are extremely important as they help bridge the
gap in terms of familiarity with many patients who want to switch from
synthetic drugs to a natural product as a way to reduce side effects and
drug,” said Mr. Kent Deuters, CEO of MJ Biopharma. “We look forward to
providing additional updates in the coming weeks,” added Mr. Deuters.
The Hemp Business Journal estimates the total U.S. CBD market will grow to $2.1 billion in consumer sales by 2020.
This news release does not constitute an offer to sell or
a solicitation of an offer to buy any of the securities in the United
States. The securities have not been and will not be registered under
the United States Securities Act of 1933, as amended (the “U.S.
Securities Act”), or any state securities laws and may not be offered or
sold within the United States or to U.S. Persons unless registered
under the U.S. Securities Act and applicable state securities laws or an
exemption from such registration is available.
The CSE does not accept responsibility for the adequacy or accuracy of this release.
Vinergy Resources Ltd.
Glen Macdonald, Director
Back to the main Media Room page, or press the Back button on your browser.